Other languages Kiniksa Pharmaceuticals, Ltd.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-28 EDT			5-day change	1st Jan Change
18.67 ^USD	+0.43%		+0.32%	+6.44%

06-26	Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday	MT
06-25	Kiniksa Pharmaceuticals Signs Deal With Samsung Biologics for Arcalyst Supply	MT

Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday	06-26
Kiniksa Collaborates With NHL Hall-of-Famer Henrik Lundqvist on Pericarditis Awareness Campaign	06-24
Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises	04-23
Kiniksa Pharmaceuticals, Ltd. Updates Earnings Guidance for 2024	04-23
Kiniksa Pharmaceuticals, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-23
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart	04-02
Kiniksa Pharmaceuticals' Q4 Earnings, Revenue Increase	02-28
Kiniksa Pharmaceuticals, Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-28
Kiniksa Pharmaceuticals, Ltd. Provides Revenue Guidance for the Year 2024	01-08
Kiniksa Pharmaceuticals, Ltd. Provides Revenue Guidance for 2023	23-10-31
Kiniksa Pharmaceuticals, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-31
Insider Sell: Kiniksa Pharmaceuticals	23-07-27
Sector Update: Health Care Stocks Steady in Late Afternoon Trading	23-07-25
Sector Update: Health Care	23-07-25
Kiniksa Pharmaceuticals' Shares Rise as Q2 Net Income, Revenue Advance	23-07-25
Top Midday Gainers	23-07-25
Kiniksa Pharmaceuticals Q2 Net Income, Revenue Gain	23-07-25
Kiniksa Pharmaceuticals, Ltd. Provides Revenue Guidance for 2023	23-07-25
Kiniksa Pharmaceuticals, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-25
Kiniksa Pharmaceuticals Jumps After Q1 Results Beat Estimates	23-05-02

No results for this search